Ocugen, Inc. Recorded Big Gain

Ocugen, Inc. (OCGN:NASDAQ) rocketted at $2.6, representing a gain of 222.9%. On Tue 22 Dec 20, OCGN:NASDAQ hit a New 2-Week High of $0.81. The stock got featured on our News Catalysts scanner on Wed 23 Dec 20 at 02:34 PM in the 'MISCELLANEOUS' category. From Tue 08 Dec 20, the stock recorded 30.00% Up Days and 27.27% Green Days

The stock spiked on Tue 28 Jul 20 at $0.96 with a volume of 301M+.

About Ocugen, Inc. (OCGN:NASDAQ)

Ocugen Inc is a clinical-stage biopharmaceutical company. It is focused on discovering, developing and commercializing a pipeline of innovative therapies that address rare and underserved eye diseases. Ocugen offers a diversified ophthalmology portfolio that includes novel gene therapies, biologics, and small molecules and targets a broad range of high-need retinal and ocular surface diseases. Its product candidate includes OCU200 and OCU300 to treat diabetic macular edema (DME), diabetic retinopathy (DR) and wet age-related macular degeneration (AMD).